Brain scans aim to predict MS drug success
NCT ID NCT02904876
First seen Mar 31, 2026 · Last updated Apr 29, 2026 · Updated 5 times
Summary
This study looked at whether special MRI scans can detect early changes in the brains of people with multiple sclerosis (MS) who are taking the drug Tysabri. The goal was to find MRI patterns that could predict how well someone responds to treatment. The study planned to follow 70 people for two years, but it was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Service de Neurologie Hôpital de Hautepierre
Strasbourg, Alsace, France
Conditions
Explore the condition pages connected to this study.